High dose rate brachytherapy boost treatment in radical radiotherapy for prostate cancer

Radiotherapy and Oncology

Volumn 57, Issue 3, 2000, Pages 285-288

  Hoskin, Peter J ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

High dose rate brachytherapy; Prostate cancer; Radiotherapy

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

BEAM THERAPY; BRACHYTHERAPY; CANCER STAGING; CANCER SURVIVAL; CONFERENCE PAPER; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE FRACTIONATION;

BRACHYTHERAPY; DOSE FRACTIONATION; HUMANS; MALE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 0034557948     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(00)00290-5     Document Type: Conference Paper

References (13)

1. Irradiation of localized prostatic carcinoma with a combination of high dose rate iridium-192 brachytherapy and external beam radiotherapy with three target definitions and dose levels inside the prostate gland
2. Fractionation and protraction for radiotherapy of prostate carcinoma
3. Transperineal percutaneous iridium-192 implant of the prostate
4. High-dose rate interstitial with external beam irradiation for localized prostate cancer: results of a prospective trial
5. Patterns of care outcome studies: results of the national practice in cancer of the cervix
6. Patterns of care studies: dose-response observations for local control of adenocarcinoma of the prostate
7. Dosimetry rules for brachytherapy using high dose rate remote afterloading implants
8. Prostate preservation by combined external beam and HDR brachytherapy at nodal negative prostate cancer patients: an intermediate analysis after ten years experience
9. External irradiation plus curietherapy boost in 108 base of tongue carcinomas
10. Predicting late rectal complications following prostate conformal radiotherapy using biologically effective doses and normalized dose-surface histograms
11. Clinical stage and Gleason score to predict pathological stage of localized prostate cancer
12. Ultrasound-guided high dose rate conformal brachytherapy boost in prostate cancer: treatment description and preliminary results of a Phase I/II clinical trial
13. Conformal high dose rate iridium-192 boost brachtherapy in locally advanced prostate cancer: superior prostate-specific antigen response compared with external beam treatment